Armata Pharmaceuticals, Inc. (ARMP) Tops Q2 EPS by 17c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q2 EPS of ($0.27), $0.17 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2.51 million versus the consensus estimate of $420 thousand.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Colgate-Palmolive explores sale of Softsoap, Irish Spring brands
• Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
• Dell Technologies (DELL) call put ratio 1.1 calls to 1 put as share price up 11%